ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink Biosciences, Inc. (OTCBB: GNLK.OB), a leading consumer genomics biotech company, today announced that it has expanded its testing capabilities through a service agreement with a nationally recognized diagnostic laboratory to process GeneLink’s SNP-based (single nucleotide polymorphism) assessments GeneLink’s DNA assessments are based on GeneLink’s scientific research and patents and utilize GeneLink’s patented DNA Collection Kit®.
